(Editor’s note: at the request of the GRC, this post has been removed.)
Joshua Finkelstein (Senior Editor, Nature)
(Editor’s note: at the request of the GRC, this post has been removed.)
Joshua Finkelstein (Senior Editor, Nature)
Mouse trials show small gain from implanted human cells.
A company set to begin clinical trials of a stem-cell treatment for a fatal brain disease has announced that the treatment boosts survival in a mouse model.
Read the story here.
Leave a Reply